(Q51820804)

13 April 2018

title

Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana. (English)

1 reference

13 April 2018

main subject

Leishmania mexicana

object named as

Leishmania mexicana

1 reference

Saravia NG

1

1 reference

13 April 2018

Hazbón MH

2

1 reference

13 April 2018

Osorio Y

3

1 reference

13 April 2018

Valderrama L

4

1 reference

13 April 2018

Walker J

5

1 reference

13 April 2018

Santrich C

6

1 reference

13 April 2018

Cortázar T

7

1 reference

13 April 2018

Lebowitz JH

8

1 reference

13 April 2018

Travi BL

9

1 reference

13 April 2018

language of work or name

English

0 references

publication date

1 January 2005

1 reference

13 April 2018

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

13 April 2018

volume

23

1 reference

13 April 2018

issue

8

1 reference

13 April 2018

page(s)

984-995

1 reference

13 April 2018

TH1 and TH2 cell antigen receptors in experimental leishmaniasis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Genetic vaccination against leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Experimental Chagas' disease: protective activity in relation with subcellular fractions of the parasite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Antigens of the Subcellular Fractions ofTrypanosoma cruzi. II. Flagellar and Membrane Fraction*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Stage-specific expression of the Leishmania mexicana paraflagellar rod protein PFR-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Flagellar membrane and paraxial rod proteins of Leishmania: characterization employing monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

The prime-boost strategy: exciting prospects for improved vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Sex-influenced response in the pathogenesis of cutaneous leishmaniasis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Sex-determined resistance against Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but not male DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Mechanisms of pathogenesis: differences amongst Leishmania species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Immune activation by bacterial DNA: a new genetic code

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Immunology. A Toll for DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Cytokine gene expression in epidermis with biological effects following injection of naked DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Rate of Leishmania-induced skin-lesion development in rodents depends on the site of inoculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

The site of cutaneous infection influences the immunological response and clinical outcome of hamsters infected with Leishmania panamensis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Marked enhancement of the antigen-specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.044

10.1016/J.VACCINE.2004.07.044

7 January 2021

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018